Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Acinetobacter baumannii with Intravenous and Intraventricular Colistin Sulfate: A Case Report and Literature Review

References

• Hernández Ortiz OH, García García HI, Muñoz Ramírez F, et al. Development of a prediction rule for diagnosing postoperative meningitis: a cross-sectional study. J Neurosurg. 2018;128(1):262–271. doi:10.3171/2016.10.JNS16379
   PubMed Web of Science ®Google Scholar
• Karvouniaris M, Brotis A, Tsiakos K, Palli E, Koulenti D. Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis. Infect Drug Resist. 2022;15:697–721. PMID: 35250284; PMCID: PMC8896765. doi:10.2147/IDR.S326456
   PubMed Web of Science ®Google Scholar
• Yang T, Wang X, Wang J, et al. In vitro toxicity study of polymyxin E on renal tubular epithelial cells. Chin J Clin Pharmacol. 2021;37(24):3363–3366+3370. doi:10.13699/j.cnki.1001-6821.2021.24.015
   Google Scholar
• Yu XB, Zhang XS, Wang YX, et al. Population pharmacokinetics of colistin sulfate in critically ill patients: exposure and clinical efficacy. Front Pharmacol. 2022;13:915958. PMID: 35784679; PMCID: PMC9243584. doi:10.3389/fphar.2022.915958
   PubMed Web of Science ®Google Scholar
• Akajagbor DS, Wilson SL, Shere-Wolfe KD, Dakum P, Charurat ME, Gilliam BL. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis. 2013;57(9):1300–1303. PMID: 23840000. doi:10.1093/cid/cit453
   PubMed Web of Science ®Google Scholar
• Zhang J-P, Yang X-S, Chen J, Peng Y-Z, Huang Y-S. Clinical evaluation of polymyxin E in the treatment of multi-drug resistant Gram-negative bacillus infection after severe burns. Chin J Burns. 2009;25(5):372–376. doi:10.3760/cma.j.issn.1009-2587.2009.05.016
   Google Scholar
• Hao M, Yang Y, Guo Y, Wu S, Hu F, Qin X. Combination regimens with colistin sulfate versus colistin sulfate monotherapy in the treatment of infections caused by carbapenem-resistant gram-negative bacilli. Antibiotics. 2022;11(10):1440. PMID: 36290098; PMCID: PMC9598655. doi:10.3390/antibiotics11101440
   Google Scholar
• Shi LY, Shi LZ, Ma Y. Efficacy of colistin sulfate combined with cefoperazone sodium sulbactam in the treatment of multi-drug resistant Acinetobacter baumannii. J Clin Pathol Sci. 2022;42(3):590–594. doi:10.3978/j.issn.2095-6959.2022.03.010
   Google Scholar
• Huang J, Mao EQ, Liu W, Qin SH, Tang YQ. Polymyxin E for the treatment of multi-drug resistant Gram-negative bacilli in 10 cases of severe infections. Chin J Infect Chemother. 2008;4:285–288. doi:10.16718/j.1009-7708.2008.04.006
   Google Scholar
• Liu GP, Shen ZY. Efficacy of polymyxin E in the treatment of severe pulmonary infections caused by pan-drug-resistant immobile bacilli and Pseudomonas aeruginosa. Med Clin Res. 2009;26(2):276–278.
   Google Scholar
• Huang J, Tang YQ, Sun JY. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections. Scand J Infect Dis. 2010;42(4):260–265. PMID: 20085424. doi:10.3109/00365540903490018
   PubMed Web of Science ®Google Scholar
• Xie YL, Jin X, Yan SS, et al. Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients. Front Pharmacol. 2022;13:967412. PMID: 36105229; PMCID: PMC9465641. doi:10.3389/fphar.2022.967412
   PubMed Web of Science ®Google Scholar
• Jin J, Zhu J, Zhu Z, et al. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study. Ann Transl Med. 2022;10(20):1137. PMID: 36388829; PMCID: PMC9652527. doi:10.21037/atm-22-4959
   PubMed Web of Science ®Google Scholar
• Bao XL, Tao T, Tang N, et al. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study. Ann Palliat Med. 2022;11(9):2939–2951. PMID: 36217623. doi:10.21037/apm-22-984
   PubMed Web of Science ®Google Scholar
• Lu X, Zhong C, Liu Y, et al. Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections. Front Med. 2022;9:1067548. PMID: 36643845; PMCID: PMC9834999. doi:10.3389/fmed.2022.1067548
   Web of Science ®Google Scholar
• Yu XB, Huang YY, Zhang XS, et al. Intraventricular colistin sulphate as a last resort therapy in a patient with multidrug-resistant Acinetobacter baumannii induced post-neurosurgical ventriculitis. Br J Clin Pharmacol. 2022;88(7):3490–3494. PMID: 35060164. doi:10.1111/bcp.15238
   PubMed Web of Science ®Google Scholar
• Lu X, Zhong C, Chen H, Xie X, Lv X. Treatment of central nervous system infection caused by multidrug-resistant Klebsiella pneumoniae with colistin sulfate intravenously and intrathecally: a case report. Pharmaceuticals. 2022;15(12):1482. PMID: 36558933; PMCID: PMC9787966. doi:10.3390/ph15121482
   Web of Science ®Google Scholar
• Xue X, Zhou T, Wang G, Zhou S. Treatment of pulmonary infection of extensively drug-resistant Acinetobacter baumannii with intravenous colistin sulfate combined with atomization: a case report. Ann Palliat Med. 2021;10(8):9288–9296. PMID: 34488415. doi:10.21037/apm-21-2112
   PubMed Web of Science ®Google Scholar
• Neurocritical Care Expert Committee of the Neurosurgeons Branch of the Chinese Physicians Association, Neurosurgery Critical Care Group of the Beijing Medical Association Neurosurgery Branch. Chinese expert consensus on the diagnosis and treatment of central nervous system infections in neurosurgery (2021 edition). Chin J Neurosurg. 2021;37(01):2–15. doi:10.3760/cma.j.cn112050-20200831-00480.
   Google Scholar
• Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006;58(6):1221–1229. PMID: 17012300. doi:10.1093/jac/dkl403
   PubMed Web of Science ®Google Scholar
• Li LM, Zheng WJ, Shi SW. Spinal arachnoiditis followed by intrathecal tigecycline therapy for central nervous system infection by extremely drug-resistant Acinetobacter baumannii. J Int Med Res. 2020;48(7):300060520920405. PMID: 32628870; PMCID: PMC7343364. doi:10.1177/0300060520920405
   PubMed Web of Science ®Google Scholar
• Yang W, Ding L, Han R, et al. Current status and trends of antimicrobial resistance among clinical isolates in China: a retrospective study of CHINET from 2018 to 2022. One Health Adv. 2023;8. doi:10.1186/s44280-023-00009-9
   Google Scholar
• Serafettin Tekgunduz K, Kara M, Caner I, Demirelli Y. Safety and efficacy of intravenous colistin in neonates with culture proven sepsis. Iran J Pediatr. 2015;25(4):e453. PMID: 26396706; PMCID: PMC4575804. doi:10.5812/ijp.453
   PubMed Web of Science ®Google Scholar
• Ziaka M, Markantonis SL, Fousteri M, et al. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother. 2013;57(4):1938–1940. PMID: 23335739; PMCID: PMC3623300. doi:10.1128/AAC.01461-12
   PubMed Web of Science ®Google Scholar
• Committee on Critical Care Medicine, Chinese Society of Research Hospitals, Committee on Evidence-Based and Translational Infectious Diseases, Chinese Society of Research Hospitals. Chinese expert consensus on the clinical application of polymyxin. Chin Crit Care Emerg Med. 2019;31(10):1194–1198. doi:10.3760/cma.j.issn.2095-4352.2019.10.003.
   Google Scholar
• Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;45(1):8–18. PMID: 25465524. doi:10.1016/j.ijantimicag.2014.10.002
   PubMed Web of Science ®Google Scholar
• Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521–547. PMID: 34923128. doi:10.1016/j.cmi.2021.11.025
   PubMed Web of Science ®Google Scholar
• Chinese Association for Medical Education, Chinese Society of Respiratory Diseases, Chinese Society of Intensive Care Medicine, et al.. Multidisciplinary expert consensus on the rational clinical application of polymyxin antibacterial drugs in China. Chin J Tuberc Respir Dis. 2021;44(4):292–310. doi:10.3760/cma.j.cn112147-20201109-01091.
   Google Scholar
• European-Medicines-Agency. Assessment report on polymyxin-based products. Referral under Article 31 of Directive 2001/83/EC. Available from https://www.ema.europa.eu/documents/referral/polymyxin-article-31-referral-assessment-report_en.pdf. Accessed January 24, 2019.
   Google Scholar
• Tsuji BT, Pogue JM, Zavascki AP, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39(1):10–39. PMID: 30710469; PMCID: PMC7437259. doi:10.1002/phar.2209
   PubMed Web of Science ®Google Scholar
• Işeri Nepesov M, Ö K, Dinleyici EÇ. Successful intraventricular colistin treatment in resistant Klebsiella pneumoniae meningitis. J Infect Dev Ctries. 2022;16(7):1226–1229. PMID: 35905029. doi:10.3855/jidc.14096
   PubMed Web of Science ®Google Scholar
• Chen L, Li X, Li D, Dong X, Chen H. Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii. Ann Palliat Med. 2022;11(2):490–497. PMID: 35249326. doi:10.21037/apm-21-3149
   PubMed Web of Science ®Google Scholar
• Chen F, Deng X, Wang Z, Wang L, Wang K, Gao L. Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin. Infect Drug Resist. 2019;12:241–247. PMID: 30718963; PMCID: PMC6345184. doi:10.2147/IDR.S186646
   PubMed Web of Science ®Google Scholar
• Bhandari RK, Pandey AK, Shafiq N, et al. Colistin disposition in the cerebrospinal fluid when administered either intravenously alone or with intraventricular/intrathecally in neonates/pediatric patients with culture-proven meningitis. Pediatr Neonatol. 2022;63(2):190–191. PMID: 35148977. doi:10.1016/j.pedneo.2021.07.012
   PubMed Web of Science ®Google Scholar
• Chusri S, Sakarunchai I, Kositpantawong N, et al. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2018;51(4):646–650. PMID: 29241820. doi:10.1016/j.ijantimicag.2017.12.002
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013;41(6):499–508. PMID: 23507414. doi:10.1016/j.ijantimicag.2013.02.006
   PubMed Web of Science ®Google Scholar
• Alnaami I, Alahmari Z. Intrathecal/intraventricular colistin for antibiotic-resistant bacterial CNS infections in pediatric population: a systematic review. Trop Med Infect Dis. 2022;7(3):41. PMID: 35324588; PMCID: PMC8954222. doi:10.3390/tropicalmed7030041
   PubMedGoogle Scholar
• Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 infectious diseases society of america’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34–e65. PMID: 28203777; PMCID: PMC5848239. doi:10.1093/cid/ciw861
   PubMed Web of Science ®Google Scholar
• Ni M, Zhao L, Zhang WJ, et al. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections. Int J Antimicrob Agents. 2021;57(3):106281. PMID: 33465459. doi:10.1016/j.ijantimicag.2021.106281
   PubMed Web of Science ®Google Scholar
• Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents. 2007;29(1):9–25. PMID: 17126534. doi:10.1016/j.ijantimicag.2006.08.024
   PubMed Web of Science ®Google Scholar